Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease

被引:158
作者
Sasso, FC
Torella, D
Carbonara, O
Ellison, GM
Torella, M
Scardone, M
Marra, C
Nasti, R
Marfella, R
Cozzolino, D
Indolfi, C
Cotrufo, M
Torella, R
Salvatore, T
机构
[1] Second Univ Naples, Inst Internal Med, Dept Geriatr & Metab Dis, I-80122 Naples, Italy
[2] Second Univ Naples, Dept Cardiothorac Resp Sci, Naples, Italy
[3] Second Univ Naples, Excellence Ctr Cardiovasc Dis, Naples, Italy
[4] Magna Graecia Univ, Div Cardiol, Catanzaro, Italy
[5] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England
关键词
D O I
10.1016/j.jacc.2005.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of the present study was to evaluate the expression and the activity of vascular endothelial growth factor (VEGF) in the hearts of diabetic patients with chronic coronary heart disease (CHD). BACKGROUND Diabetes is characterized by a decreased collateral vessel formation in response to coronary ischemic events, although the role of VEGF in human diabetic macroangiopathy has not been fully investigated. METHODS Biopsies of left ventricular (LV) myocardium were obtained from 10 patients with type 2 diabetes and 10 non-diabetic patients with chronic CHD, all undergoing surgical coronary revascularization. Right ventricle myocardial samples taken from normal hearts were used as control specimens. Vascular endothelial growth factor and VEGF-receptors (flt-1 and flk-1) were evaluated by Western blot, reverse transcriptase-polymerase chain reaction (RT-PCR) and real-time RT-PCR. Akt and endothelial nitric oxide synthase (eNOS) protein expression and their phosphorylated forms were also evaluated by Western blot. RESULTS Vascular endothelial growth factor, flt-1, and flk-1 messenger ribonucleic acid (mRNA) and protein expressions were increased in non-diabetic patients with CHD compared with control subjects. Remarkably, in diabetic patients, VEGF mRNA and protein levels were significantly higher, whereas fit-1, flk-1 mRNA, and protein were lower when compared with nondiabetic patients. Interestingly, phospho-flk-1 was reduced in diabetic patients compared with non-diabetic patients. As a consequence, Akt phosphorylation, eNOS protein and its phosphorylated form were significantly higher in the samples from non-diabetic patients compared with diabetic patients. CONCLUSIONS Chronic CHD in diabetic patients is characterized by an increased VEGF myocardial expression and a decreased expression of its receptors along with a down-regulation of its signal transduction. The latter could be partially responsible for the reduced neoangiogenesis in diabetic patients with ischemic cardiomyopathy.
引用
收藏
页码:827 / 834
页数:8
相关论文
共 37 条
[11]   Diabetic retinopathy [J].
Frank, RN .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) :48-58
[12]   Myocardial cell death in human diabetes [J].
Frustaci, A ;
Kajstura, J ;
Chimenti, C ;
Jakoniuk, I ;
Leri, A ;
Maseri, A ;
Nadal-Ginard, B ;
Anversa, P .
CIRCULATION RESEARCH, 2000, 87 (12) :1123-1132
[13]   Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner [J].
Fujio, Y ;
Walsh, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16349-16354
[14]   Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase Akt signal transduction pathway -: Requirement for Flk-1/KDR activation [J].
Gerber, HP ;
McMurtrey, A ;
Kowalski, J ;
Yan, MH ;
Keyt, BA ;
Dixit, V ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30336-30343
[15]   Diabetes and cardiovascular disease - A statement for healthcare professionals from the American Heart Association [J].
Grundy, SM ;
Benjamin, IJ ;
Burke, GL ;
Chait, A ;
Eckel, RH ;
Howard, BV ;
Mitch, W ;
Smith, SC ;
Sowers, JR .
CIRCULATION, 1999, 100 (10) :1134-1146
[16]   The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. [J].
Kureishi, Y ;
Luo, ZY ;
Shiojima, I ;
Bialik, A ;
Fulton, D ;
Lefer, DJ ;
Sessa, WC ;
Walsh, K .
NATURE MEDICINE, 2000, 6 (09) :1004-1010
[17]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IS A SECRETED ANGIOGENIC MITOGEN [J].
LEUNG, DW ;
CACHIANES, G ;
KUANG, WJ ;
GOEDDEL, DV ;
FERRARA, N .
SCIENCE, 1989, 246 (4935) :1306-1309
[18]   VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis [J].
Li, J ;
Brown, LF ;
Hibberd, MG ;
Grossman, JD ;
Morgan, JP ;
Simons, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 270 (05) :H1803-H1811
[19]   Stretch-induced VEGF expression in the heart [J].
Li, J ;
Hampton, T ;
Morgan, JP ;
Simons, M .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (01) :18-24
[20]   Therapeutic angiogenesis and vasculogenesis for ischemic disease - Part II: Cell-based therapies [J].
Losordo, DW ;
Dimmeler, S .
CIRCULATION, 2004, 109 (22) :2692-2697